The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model

被引:35
|
作者
Matsuzaki, Yuichi [1 ]
Iwaki, Ryuma [1 ]
Reinhardt, James W. [1 ]
Chang, Yu-Chun [1 ,2 ]
Miyamoto, Shinka [1 ]
Kelly, John [1 ]
Zbinden, Jacob [1 ,3 ]
Blum, Kevin [1 ,3 ]
Mirhaidari, Gabriel [1 ,2 ]
Ulziibayar, Anudari [1 ]
Shoji, Toshihiro [1 ]
Breuer, Christopher K. [1 ,4 ]
Shinoka, Toshiharu [1 ,4 ,5 ]
机构
[1] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Regenerat Med, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Biomed Engn Grad Program, Columbus, OH 43210 USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Dept Surg, Columbus, OH 43210 USA
[5] Nationwide Childrens Hosp, Heart Ctr, Dept Cardiothorac Surg, 700 Childrens Dr,T2294, Columbus, OH 43205 USA
关键词
Tissue engineering; Vascular graft; Biodegradable; Artery; Pore diameter; Large animal model; VASCULAR GRAFTS; POLARIZATION; FIBERS;
D O I
10.1016/j.actbio.2020.08.011
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To date, there has been little investigation of biodegradable tissue engineered arterial grafts (TEAG) using clinically relevant large animal models. The purpose of this study is to explore how pore size of electrospun scaffolds can be used to balance neoarterial tissue formation with graft structural integrity under arterial environmental conditions throughout the remodeling process. TEAGs were created with an outer poly-epsilon-caprolactone (PCL) electrospun layer and an inner sponge layer composed of heparin conjugated 50:50 poly (l-lactide-co-epsilon-caprolactone) copolymer (PLCL). Outer electrospun layers were created with four different pore diameters (4, 7, 10, and 15 mu m). Fourteen adult female sheep underwent bilateral carotid artery interposition grafting (n = 3-4 /group). Our heparin-eluting TEAG was implanted on one side (n = 14) and ePTFE graft (n = 3) or non-heparin-eluting TEAG (n = 5) on the other side. Twelve of the fourteen animals survived to the designated endpoint at 8 weeks, and one animal with 4 mu m pore diameter graft was followed to 1 year. All heparin-eluting TEAGs were patent, but those with pore diameters larger than 4 mu m began to dilate at week 4. Only scaffolds with a pore diameter of 4 mu m resisted dilation and could do so for up to 1 year. At 8 weeks, the 10 mu m pore graft had the highest density of cells in the electrospun layer and macrophages were the primary cell type present. This study highlights challenges in designing bioabsorbable TEAGs for the arterial environment in a large animal model. While larger pore diameter TEAGs promoted cell infiltration, neotissue could not regenerate rapidly enough to provide sufficient mechanical strength required to resist dilation. Future studies will be focused on evaluating a smaller pore design to better understand long-term remodeling and determine feasibility for clinical use. Statement of Significance In situ vascular tissue engineering relies on a biodegradable scaffold that encourages tissue regeneration and maintains mechanical integrity until the neotissue can bear the load. Species-specific differences in tissue regeneration and larger mechanical forces often result in graft failure when scaling up from small to large animal models. This study utilizes a slow-degrading electrospun PCL sheath to reinforce a tissue engineered arterials graft. Pore size, a property critical to tissue regeneration, was controlled by changing PCL fiber diameter and the resulting effects of these properties on neotissue formation and graft durability was evaluated. This study is among few to report the effect of pore size on vascular neotissue formation in a large animal arterial model and also demonstrate robust neotissue formation. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 50 条
  • [21] Developments towards tissue-engineered, small-diameter arterial substitutes
    Bordenave, Laurence
    Menu, Patrick
    Baquey, Charles
    EXPERT REVIEW OF MEDICAL DEVICES, 2008, 5 (03) : 337 - 347
  • [22] Tissue-Engineered Small Intestine and Stomach Form from Autologous Tissue in a Preclinical Large Animal Model
    Sala, Frederic G.
    Kunisaki, Shaun M.
    Ochoa, Erin R.
    Vacanti, Joseph
    Grikscheit, Tracy C.
    JOURNAL OF SURGICAL RESEARCH, 2009, 156 (02) : 205 - 212
  • [23] Functional growth in tissue-engineered living, vascular grafts -: Follow-up at 100 weeks in a large animal model
    Hoerstrup, Simon P.
    Cummings, Ian
    Lachat, Mario
    Schoen, Frederick J.
    Jenni, Rolf
    Leschka, Sebastian
    Neuenschwander, Stefan
    Schmidt, Dorthe
    Mol, Anita
    Guenter, Christina
    Goessi, Mathias
    Genoni, Michele
    Zund, Gregor
    CIRCULATION, 2006, 114 : I159 - I166
  • [24] Construction and characterization of an electrospun tubular scaffold for small-diameter tissue-engineered vascular grafts: A scaffold membrane approach
    Hu, Jin-Jia
    Chao, Wei-Chih
    Lee, Pei-Yuan
    Huang, Chih-Hao
    JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS, 2012, 13 : 140 - 155
  • [25] Small Diameter Tissue Engineered Vascular Grafts for Arterial Bypass Applications
    Kurobe, Hirotsugu
    Maxfield, Mark W.
    Tara, Shuhei
    Bagi, Paul S.
    Nakayama, Hidetaka
    Sakamoto, Yuki
    Taki, Kensuke
    Yi, Tai
    Rocco, Kevin A.
    Zhuang, Zhen W.
    Iwakiri, Yasuko
    Breuer, Christopher K.
    Shinoka, Toshiharu
    CIRCULATION, 2013, 128 (22)
  • [26] Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model
    Reinhardt, James W.
    Rosado, Juan de Dios Ruiz
    Barker, Jenny C.
    Lee, Yong-Ung
    Best, Cameron A.
    Yi, Tai
    Zeng, Qiang
    Partida-Sanchez, Santiago
    Shinoka, Toshiharu
    Breuer, Christopher K.
    REGENERATIVE MEDICINE, 2019, 14 (05) : 389 - 408
  • [27] Effect of implantation site on outcome of tissue-engineered vascular grafts
    Sologashvili, Tornike
    Saat, Shahrul A.
    Tille, Jean-Christophe
    De Valence, Sarra
    Mugnai, Damiano
    Giliberto, Jean Pierre
    Dillon, Jeswant
    Yakub, Azhari
    Dimon, Zamrin
    Gurny, Robert
    Walpoth, Beat H.
    Moeller, Michael
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2019, 139 : 272 - 278
  • [28] Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model
    Fukunishi, Takuma
    Best, Cameron A.
    Sugiura, Tadahisa
    Shoji, Toshihiro
    Yi, Tai
    Udelsman, Brooks
    Ohst, Devan
    Ong, Chin Siang
    Zhang, Huaitao
    Shinoka, Toshiharu
    Breuer, Christopher K.
    Johnson, Jed
    Hibino, Narutoshi
    PLOS ONE, 2016, 11 (07):
  • [29] Successful Creation of Tissue-Engineered Autologous Auricular Cartilage in an Immunocompetent Large Animal Model
    Bichara, David A.
    Pomerantseva, Irina
    Zhao, Xing
    Zhou, Libin
    Kulig, Katherine M.
    Tseng, Alan
    Kimura, Anya M.
    Johnson, Matthew A.
    Vacanti, Joseph P.
    Randolph, Mark A.
    Sundback, Cathryn A.
    TISSUE ENGINEERING PART A, 2014, 20 (1-2) : 303 - 312
  • [30] DESIGN OF A BIOREACTOR SYSTEM FOR THE MECHANICAL CONDITIONING OF SMALL DIAMETER TISSUE-ENGINEERED VASCULAR GRAFTS
    Diamantouros, S. E.
    Flanagan, T. C.
    Finocchiaro, T.
    Deichmann, T.
    Wilhelmi, M.
    Schmitz-Rode, T.
    Jockenhoevel, S.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (07): : 458 - 458